This information was published on 2026-05-26T10:10:47 for IP Right Registration Published.
| Field | Value |
| (210) | 2536687 (IR 1847695) |
| (220) |
25 Feb 2025
|
| (300) |
US, 06 Sep 2024, 98737774
|
| (511) (510) |
Class 1
Assays and reagents for use in genetic research; reagents for medical research; reagents for research purposes; reagents for scientific purposes. Class 5 Biological preparations for the treatment of gene expression; biological reagents for medical use; diagnostic preparations for medical purposes for detecting genetic predispositions; pharmaceutical preparations for the treatment of muscular dystrophy, hypercholesterolemia, liver diseases, lung diseases, ophthalmic diseases, and cancer; pharmaceutical preparations for controlling gene expression. Class 44 Consultancy in the field of the medical treatment of genetic diseases; genetic testing for medical purposes; providing information about genetic testing for medical purposes; providing medical information in the field of gene expression; providing medical information via a website. |
| (540) | EPICRISPR |
| (550) | Word |
| (730) |
Epicrispr Biotechnologies, Inc.
|
| (750) |
Chapman Tripp
|
Find out more about publications on the About page.